Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1892 1
1898 1
1905 2
1907 1
1908 1
1909 1
1910 2
1911 2
1912 1
1913 1
1914 1
1915 1
1916 1
1917 1
1919 1
1920 1
1922 1
1924 2
1925 1
1926 1
1927 1
1929 1
1930 1
1931 5
1933 3
1936 1
1938 2
1939 1
1940 1
1943 1
1944 2
1945 36
1946 66
1947 49
1948 73
1949 90
1950 111
1951 186
1952 244
1953 222
1954 230
1955 189
1956 165
1957 187
1958 146
1959 121
1960 151
1961 121
1962 143
1963 201
1964 265
1965 202
1966 210
1967 273
1968 266
1969 325
1970 335
1971 325
1972 324
1973 366
1974 389
1975 433
1976 399
1977 466
1978 447
1979 492
1980 524
1981 554
1982 508
1983 616
1984 677
1985 730
1986 734
1987 721
1988 794
1989 1005
1990 1046
1991 1121
1992 1171
1993 1260
1994 1230
1995 1325
1996 1510
1997 1569
1998 1517
1999 1673
2000 1699
2001 1649
2002 1679
2003 1712
2004 1696
2005 1843
2006 1903
2007 1972
2008 2053
2009 2122
2010 2097
2011 2309
2012 2383
2013 2568
2014 2682
2015 2749
2016 2853
2017 2993
2018 3119
2019 3201
2020 3058
Text availability
Article attribute
Article type
Publication date

Search Results

72,128 results
Results by year
Filters applied: . Clear all
Page 1
Update on eosinophilic granulomatosis with polyangiitis.
Furuta S, Iwamoto T, Nakajima H. Furuta S, et al. Allergol Int. 2019 Oct;68(4):430-436. doi: 10.1016/j.alit.2019.06.004. Epub 2019 Jun 29. Allergol Int. 2019. PMID: 31266709 Free article. Review.
Eosinophilic granulomatosis with polyangiitis (EGPA) (formerly Churg-Strauss syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis characterized by eosinophil-rich granulomatous inflammation and small to medium-size vessel vascu
Eosinophilic granulomatosis with polyangiitis (EGPA) (formerly Churg-Strauss syndrome) is a rare form of anti-neutrophil cytoplasm an
The Eosinophil in Infection.
Ravin KA, Loy M. Ravin KA, et al. Clin Rev Allergy Immunol. 2016 Apr;50(2):214-27. doi: 10.1007/s12016-015-8525-4. Clin Rev Allergy Immunol. 2016. PMID: 26690368 Review.
Over the past 30 years, research has helped to elucidate the complexity of the eosinophil's function and establish its role in host defense and immunity. ...In this paper, we review the eosinophil's unique biology and structure, including its character …
Over the past 30 years, research has helped to elucidate the complexity of the eosinophil's function and establish its role in …
Eosinophilic Skin Diseases: A Comprehensive Review.
Long H, Zhang G, Wang L, Lu Q. Long H, et al. Clin Rev Allergy Immunol. 2016 Apr;50(2):189-213. doi: 10.1007/s12016-015-8485-8. Clin Rev Allergy Immunol. 2016. PMID: 25876839 Review.
Eosinophilic skin diseases, commonly termed as eosinophilic dermatoses, refer to a broad spectrum of skin diseases characterized by eosinophil infiltration and/or degranulation in skin lesions, with or without blood eosinophilia. ...Besides these, there are s
Eosinophilic skin diseases, commonly termed as eosinophilic dermatoses, refer to a broad spectrum of skin diseases characteriz
Eosinophils and eosinophil-associated diseases: An update.
O'Sullivan JA, Bochner BS. O'Sullivan JA, et al. J Allergy Clin Immunol. 2018 Feb;141(2):505-517. doi: 10.1016/j.jaci.2017.09.022. Epub 2017 Oct 16. J Allergy Clin Immunol. 2018. PMID: 29045815 Free PMC article.
This particular assignment was to cover the topic of eosinophils. In an attempt to highlight major ideas, themes, trends, and advances relevant to basic and clinical aspects of eosinophil biology, a search of articles published since 2015 in the Journal of Allergy a …
This particular assignment was to cover the topic of eosinophils. In an attempt to highlight major ideas, themes, trends, and advance …
Eosinophil Development, Disease Involvement, and Therapeutic Suppression.
Fulkerson PC, Rothenberg ME. Fulkerson PC, et al. Adv Immunol. 2018;138:1-34. doi: 10.1016/bs.ai.2018.03.001. Epub 2018 Apr 22. Adv Immunol. 2018. PMID: 29731004 Review.
Eosinophils are terminally differentiated and do not proliferate once they leave the bone marrow. The cytokine IL-5 specifically enhances eosinophil production and, along with other mediators, promotes eosinophil activation. Indeed, eosinophil depletio
Eosinophils are terminally differentiated and do not proliferate once they leave the bone marrow. The cytokine IL-5 specifically enha
Eosinophil-Related Disease and the Skin.
Leiferman KM, Peters MS. Leiferman KM, et al. J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1462-1482.e6. doi: 10.1016/j.jaip.2018.06.002. Epub 2018 Jun 12. J Allergy Clin Immunol Pract. 2018. PMID: 29902530 Review.
The eosinophil has potent proinflammatory activities, particularly, through the effects of its toxic granule proteins. In addition, eosinophils have prothrombotic and profibrotic activities. ...Skin involvement is common in eosinophil-related systemic disease …
The eosinophil has potent proinflammatory activities, particularly, through the effects of its toxic granule proteins. In addition, …
The Regulatory Function of Eosinophils.
Wen T, Rothenberg ME. Wen T, et al. Microbiol Spectr. 2016 Oct;4(5):10.1128/microbiolspec.MCHD-0020-2015. doi: 10.1128/microbiolspec.MCHD-0020-2015. Microbiol Spectr. 2016. PMID: 27780017 Free PMC article. Review.
During homeostasis, eosinophils develop in the bone marrow and migrate from the blood into target tissues following an eotaxin gradient, with interleukin-5 being a key cytokine for eosinophil proliferation, survival, and priming. ...The immunologic regulation of …
During homeostasis, eosinophils develop in the bone marrow and migrate from the blood into target tissues following an eotaxin gradie …
Targeting eosinophils in allergy, inflammation and beyond.
Fulkerson PC, Rothenberg ME. Fulkerson PC, et al. Nat Rev Drug Discov. 2013 Feb;12(2):117-29. doi: 10.1038/nrd3838. Epub 2013 Jan 21. Nat Rev Drug Discov. 2013. PMID: 23334207 Free PMC article. Review.
Eosinophil-targeted therapeutic agents that are aimed at blocking specific steps involved in eosinophil development, migration and activation have recently entered clinical testing and have produced encouraging results and insights into the role of eosinophils
Eosinophil-targeted therapeutic agents that are aimed at blocking specific steps involved in eosinophil development, migration
Eosinophils: Friends or Foes?
Chusid MJ. Chusid MJ. J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1439-1444. doi: 10.1016/j.jaip.2018.04.031. J Allergy Clin Immunol Pract. 2018. PMID: 30197067 Review.
The concept has emerged that eosinophils play a major role in the modulation of allergic inflammation and in the repair of damaged tissues in diseases characterized by eosinophilic infiltration. ...The eosinophil granulocyte line appeared hundreds of millions …
The concept has emerged that eosinophils play a major role in the modulation of allergic inflammation and in the repair of damaged ti …
Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation.
Ueki S, Tokunaga T, Fujieda S, Honda K, Hirokawa M, Spencer LA, Weller PF. Ueki S, et al. Curr Allergy Asthma Rep. 2016 Jul;16(8):54. doi: 10.1007/s11882-016-0634-5. Curr Allergy Asthma Rep. 2016. PMID: 27393701 Free PMC article. Review.
Recent evidence indicates that activated eosinophils can exhibit a non-apoptotic cell death pathway, namely extracellular trap cell death (ETosis) that mediates the eosinophil cytolytic degranulation. Here, we discuss the current concept of eosinophil ETosis …
Recent evidence indicates that activated eosinophils can exhibit a non-apoptotic cell death pathway, namely extracellular trap cell d …
72,128 results
Jump to page
Feedback